eLaws | eCases | United States Code | Federal Courts |
Home » 2020 Issues » 85 FR (07/23/2020) » 2020-15932. Notice of Meeting

2020-15932. Notice of Meeting  

  • Start Preamble

    AGENCY:

    Agency for Healthcare Research and Quality, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Agency for Healthcare Research and Quality (AHRQ) announces a Special Emphasis Panel (SEP) meeting on “AHRQ RFAHS20-002 Supporting Primary Care to Advance Cardiovascular Health in States with High Prevalence of Preventable CVD Events (U18).” This SEP meeting will be closed to the public.

    DATES:

    August 25, 2020.

    ADDRESSES:

    Agency for Healthcare Research and Quality, (Video Assisted Review), 5600 Fishers Lane, Rockville, Maryland 20850.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Jenny Griffith, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20850, Telephone: (301) 427-1557.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by AHRQ, and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularly-scheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise.

    The SEP meeting referenced above will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for the “AHRQ RFAHS20-002 Supporting Primary Care to Advance Cardiovascular Health in States with High Prevalence of Preventable CVD Events (U18).” are to be reviewed and discussed at this meeting. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Agenda items for this meeting are subject to change as priorities dictate.

    Start Signature

    Dated: July 17, 2020.

    Virginia L. Mackay-Smith,

    Associate Director.

    End Signature End Supplemental Information

    [FR Doc. 2020-15932 Filed 7-22-20; 8:45 am]

    BILLING CODE 4160-90-P

Visit the Official Version
Leave a Comment

Document Information

Published:
07/23/2020
Department:
Agency for Healthcare Research and Quality
Entry Type:
Notice
Action:
Notice.
Document Number:
2020-15932
Dates:
August 25, 2020.
Pages:
44537-44537 (1 pages)
PDF File:
2020-15932.pdf
Supporting Documents:
» Supplemental Evidence and Data Request: Transitions of Care from Pediatric to Adult Services for Children with Special Healthcare Needs
» Meetings
» Supplemental Evidence and Data Request: Continuous Positive Airway Pressure Treatment for Obstructive Sleep Apnea in Medicare Eligible Patients
» Agency Information Collection Activities; Proposals, Submissions, and Approvals
» Request for Nominations: Members of the National Advisory Council for Healthcare Research and Quality
» Supplemental Evidence and Data Request: Safety of Vaccines Used for Routine Immunization in the United States
» Agency Information Collection Activities; Proposals, Submissions, and Approvals
» Supplemental Evidence and Data Request: Platelet-Rich Plasma for Wound Care in the Medicare Population
» Agency Information Collection Activities; Proposals, Submissions, and Approvals
» Meetings: National Advisory Council for Healthcare Research and Quality